» Articles » PMID: 19002695

Preventive Effects of Curcumin on Different Aspiration Material-induced Lung Injury in Rats

Overview
Date 2008 Nov 13
PMID 19002695
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: We have studied whether curcumin protects different pulmonary aspiration material-induced lung injury in rats.

Materials And Methods: The experiments were designed in 60 Sprague-Dawley rats, randomly allotted into one of six groups (n=10): normal saline (NS, control), enteral formula (Biosorb Energy Plus, BIO), hydrochloric acid (HCl), NS+curcumin-treated, BIO+curcumin-treated, and HCl+curcumin-treated. NS, BIO, HCl were injected in to the lungs. The rats received curcumin twice daily only for 7 days. Seven days later, both lungs in all groups were examined histopathologically, immunohistochemically, and biochemically. Histopathologic examination was performed according to the presence of peribronchial inflammatory cell infiltration, alveolar septal infiltration, alveolar edema, alveolar exudate, alveolar histiocytes, interstitial fibrosis, granuloma, and necrosis formation. Immunohistochemical assessments were examined for the activity of inducible nitric oxide synthase (iNOS) and the expression of surfactant protein D (SP-D). Malondialdehyde (MDA), hydroxyproline (HP), superoxide dismutase (SOD), and glutathione peroxidase (GSH-Px) activity were measured in the lung tissue.

Results: Our findings show that curcumin inhibits the inflammatory response reducing significantly (P<0.05) all histopathological parameters in different pulmonary aspiration models. Pulmonary aspiration significantly increased the tissue HP content, MDA levels and decreased the antioxidant enzyme (SOD, GSH-Px) activities. Curcumin treatment significantly decreased the elevated tissue HP content, and MDA levels and prevented inhibition of SOD, and GSH-Px enzymes in the tissues. Furthermore, our data suggest that there is a significant reduction in the activity of iNOS and a rise in the expression of SP-D in lung tissue of different pulmonary aspiration models with curcumin therapy.

Conclusion: Our findings support the use of curcumin as a potential therapeutic agent in acute lung injury.

Citing Articles

Global research status and trends of interactions between Traditional Chinese medicine and pulmonary fibrosis: A new dawn in treatment.

Wei B, Li H, Wang C, Hu J Heliyon. 2024; 10(14):e34592.

PMID: 39149021 PMC: 11325230. DOI: 10.1016/j.heliyon.2024.e34592.


Therapeutic potential of curcumin in ARDS and COVID-19.

Suresh M, Francis S, Aktay S, Kralovich G, Raghavendran K Clin Exp Pharmacol Physiol. 2022; 50(4):267-276.

PMID: 36480131 PMC: 9877870. DOI: 10.1111/1440-1681.13744.


Targeting Oxidative Stress as a Therapeutic Approach for Idiopathic Pulmonary Fibrosis.

Estornut C, Milara J, Bayarri M, Belhadj N, Cortijo J Front Pharmacol. 2022; 12:794997.

PMID: 35126133 PMC: 8815729. DOI: 10.3389/fphar.2021.794997.


In Vivo Anti-inflammatory Potential of Viscozyme-Treated Jujube Fruit.

Kim Y, Oh J, Jang C, Lim J, Lee J, Kim J Foods. 2020; 9(8).

PMID: 32752184 PMC: 7466189. DOI: 10.3390/foods9081033.


Ameliorative effects of silymarin on HCl-induced acute lung injury in rats; role of the Nrf-2/HO-1 pathway.

Ahmed R, Moussa R, Eldemerdash R, Zakaria M, Abdel-Gaber S Iran J Basic Med Sci. 2020; 22(12):1483-1492.

PMID: 32133068 PMC: 7043873. DOI: 10.22038/IJBMS.2019.14069.


References
1.
Bogdan C . Nitric oxide and the immune response. Nat Immunol. 2001; 2(10):907-16. DOI: 10.1038/ni1001-907. View

2.
Kivirikko K, Laitinen O, Prockop D . Modifications of a specific assay for hydroxyproline in urine. Anal Biochem. 1967; 19(2):249-55. DOI: 10.1016/0003-2697(67)90160-1. View

3.
Bachofen M, Weibel E . Structural alterations of lung parenchyma in the adult respiratory distress syndrome. Clin Chest Med. 1982; 3(1):35-56. View

4.
Metheny N, Clouse R, Chang Y, Stewart B, Oliver D, Kollef M . Tracheobronchial aspiration of gastric contents in critically ill tube-fed patients: frequency, outcomes, and risk factors. Crit Care Med. 2006; 34(4):1007-15. PMC: 2396145. DOI: 10.1097/01.CCM.0000206106.65220.59. View

5.
Nathan C, Xie Q . Nitric oxide synthases: roles, tolls, and controls. Cell. 1994; 78(6):915-8. DOI: 10.1016/0092-8674(94)90266-6. View